Association of DROSHA Variants with Susceptibility and Outcomes in Childhood Acute Lymphoblastic Leukemia
2025
Ioannis Kyriakidis | Iordanis Pelagiadis | Charalampos Pontikoglou | Helen A. Papadaki | Eftichia Stiakaki
MicroRNAs are key regulators of lymphoid differentiation, exhibiting a pivotal role in acute lymphoblastic leukemia (ALL) biology and prognosis. The initial steps of canonical miRNA biogenesis involve the microprocessor complex processing the primary miRNA transcripts into precursor miRNAs via Drosha. DROSHA polymorphisms have been implicated in pediatric ALL and linked with cancer risk. This study investigated the role of rs642321, rs3805500, and rs10035440 DROSHA polymorphisms in ALL susceptibility, relapse, and outcomes in children and adolescents of Greek descent. The study included 252 children and adolescents (115 ALL cases and 137 controls). Genotyping was performed using RT-qPCR and the TaqMan Genotyping Assay. Homozygotes for the minor allele in DROSHA rs642321 were nominally associated with ALL susceptibility (TT vs. CC+CT: OR 4.5: 95% CI: 1.2&ndash:21.2: padj = 0.034). Likewise, homozygotes for the minor allele in rs3805500 were linked with ALL risk (GG vs. AA+AG: OR 2.7: 95% CI: 1.3&ndash:6.1: padj = 0.012). A suggestive association was observed between the rs3805500 AG genotype and both relapsed (OR 5.8: 95% CI: 1.6&ndash:24.3: padj = 0.011) and deceased cases (OR 5: 95% CI: 1.1&ndash:26.3: padj = 0.038). Patients with the rs3805500 AG and GG genotypes showed a trend toward poorer overall survival rates. In summary, certain haplotypes of DROSHA polymorphisms may be modestly associated with the occurrence of childhood ALL and its outcomes, although these findings require validation in larger, independent cohorts.
显示更多 [+] 显示较少 [-]